Synergy Rx vs Vytora Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Synergy Rx
Best for broadest drug catalog in the Lion MD white-label clusterStarting at $199/mo
Vytora Health
Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.Starting at $150/mo
Side-by-Side Comparison
| Feature | Synergy Rx | Vytora Health |
|---|---|---|
| Overall Score | 7.4/10 | ✓8.7/10 |
| Starting Price | $199/mo | ✓$150/mo |
| Editorial Rating | 3.7 ★ /5 | ✓4.4 ★ /5 |
| Features | 6 features | ✓10 features |
| States Available | 0 | ✓51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Synergy Rx
Pros
- ✓Broad drug catalog: compounded sema/tirz in both injection and oral dissolving tablet formats, plus brand-name Ozempic, Wegovy, and Mounjaro
- ✓Claims 50,000+ patients per homepage as of late 2025
- ✓All 50 US states subject to state telehealth regulations
- ✓Same named medical team as Breeze Meds and Care Bare Rx (Dr. Carr and Dr. Tenbrink via Lion MD)
- ✓Four named 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
- ✓LegitScript seal displayed in footer
Cons
- ✗Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Breeze Meds and Care Bare Rx — the three brands are white-labeled storefronts on top of one underlying operation
- ✗Mandatory individual arbitration + class action waiver in ToS (30-day opt-out window from signup)
- ✗Consultation fees are non-refundable and all prescription sales are final per ToS
- ✗Platform explicitly disclaims liability for third-party pharmacy medication quality: 'SynergyRx makes no representations or warranties regarding the efficacy, safety, or outcomes of any medication provided through these third parties'
- ✗State availability is 'subject to each state's telehealth and prescribing regulations' — the full list of active states requires contacting customer service rather than being published
- ✗Do NOT confuse with the unrelated 'Synergy Rx Pharmacy' (San Diego, CA) that issued a voluntary nationwide recall in February 2017 for non-sterile compounded products — that is a different entity in a different state
- ✗Do not visit synergyrx.com — it is a parked domain on Sedo and unrelated to the telehealth brand. The correct domain is synergyrx.co
Vytora Health
Pros
- ✓All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
- ✓Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
- ✓LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
- ✓Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
- ✓Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
- ✓Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens
Cons
- ✗Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
- ✗Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
- ✗Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
- ✗Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
- ✗Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)
Our Verdict
Vytora Health edges out Synergy Rx with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. Synergy Rx remains a solid alternative, especially if you're looking for broadest drug catalog in the Lion MD white-label cluster.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Synergy Rx and Vytora Health head-to-heads in the same category.
- Synergy Rx vs CoreAge Rx
- Synergy Rx vs TrimRx
- Synergy Rx vs Amazon One Medical
- Vytora Health vs NovoCare Pharmacy
- Vytora Health vs Enhance MD
- Vytora Health vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.